PHYSIOLOGIC LONG-ACTING BASAL INSULIN, INTERACTIVE (ARS) CASE MANGEMEMENT SESSION #1 - Pablo Mora, MD, MSc, FACE, CDE
Applying Updated ADA/EASD Guidelines to a Patient with T2D Who Has Not Achieved Ideal HA1c Levels with Metformin plus an SGLT-2 Inhibitor and Who is at Moderate to Significant Risk for Hypoglycemia.
Related Presenters
Dallas Diabetes Research Center at Medical City Dallas (Texas)Adjunct Associate Professor University of Texas Southwestern Medical Center at Dallas (Texas)